Idoven

Idoven develops Willem, a cloud-based AI platform that analyses electrocardiograms (ECGs) from resting, holter, patch and implantable devices. It detects 22 cardiac patterns and four intervals, and returns a report to the physician. Willem is CE marked as Medical Device Class IIa under EU MDR and is offered through an API and non-API tools for bi-directional data exchange with EHR systems.

Customers include MedTech and life sciences companies, which use the platform for R&D, digital biomarkers and risk stratification, and organisations that run remote ECG screening programmes. The website describes licensing the technology to industry partners and providing screening services; pricing terms are not stated.

The company was founded in 2018 and is based in Madrid, Spain. Its 2022 Series A of €18.5M was co-led by Insight Partners and Northzone, and it has collaborations with AstraZeneca, Abbott and Banco Santander. Its current open roles include a VP of Commercial based in Madrid (remote) and a general technology position in Madrid.

Product: Willem, a cloud-based AI ECG analysis platform (CE Class IIa, EU MDR) accessed via API to detect 22 cardiac patterns from ECG devices.